BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 25400185)

  • 1. A unique case of γ-heavy chain deposition disease characterized by concomitant deposition of γ2 and γ4 subclasses.
    Yin G; Wu Y; Zeng CH; Chen HP; Liu ZH
    Intern Med; 2014; 53(22):2615-8. PubMed ID: 25400185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of γ1-heavy chain deposition disease successfully treated with melphalan and prednisolone therapy.
    Oe Y; Nakaya I; Yahata M; Sakuma T; Sato H; Soma J
    Intern Med; 2010; 49(14):1411-5. PubMed ID: 20647658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heavy Chain Deposition Disease: Clinicopathologic Characteristics of a Chinese Case Series.
    Zhang Y; Li X; Liang D; Xu F; Liang S; Zhu X; Zheng N; Huang X; Liu Z; Zeng C
    Am J Kidney Dis; 2020 May; 75(5):736-743. PubMed ID: 31699519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heavy chain deposition disease: recurrence in a renal transplant and report of IgG(2) subtype.
    Herzenberg AM; Kiaii M; Magil AB
    Am J Kidney Dis; 2000 May; 35(5):E25. PubMed ID: 10793054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of renal γ2 heavy-chain deposition disease accompanied by rapid progressive renal failure.
    Chen GT; Liao XH; Yan RY; Li Y; Zhang L
    Ir J Med Sci; 2014 Jun; 183(2):319-21. PubMed ID: 23963539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal crescentic alpha heavy chain deposition disease: a report of 3 cases and review of the literature.
    Alexander MP; Nasr SH; Watson DC; Méndez GP; Rennke HG
    Am J Kidney Dis; 2011 Oct; 58(4):621-5. PubMed ID: 21944962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term renal survival of γ3-heavy chain deposition disease: a case report.
    Katsuno T; Mizuno S; Mabuchi M; Tsuboi N; Komatsuda A; Maruyama S
    BMC Nephrol; 2017 Jul; 18(1):239. PubMed ID: 28716013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heavy chain deposition disease: the disease spectrum.
    Kambham N; Markowitz GS; Appel GB; Kleiner MJ; Aucouturier P; D'agati VD
    Am J Kidney Dis; 1999 May; 33(5):954-62. PubMed ID: 10213655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gamma 1-heavy chain deposition disease accompanied by IgG kappa in serum, urine, and bone marrow.
    Kaneko K; Seta K; Soma J; Kuwahara T; Koizumi M; Kikuchi Y; Sugawara A; Yahata K
    CEN Case Rep; 2014 May; 3(1):44-48. PubMed ID: 28509245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgG heavy-chain deposition disease.
    Katz A; Zent R; Bargman JM
    Mod Pathol; 1994 Oct; 7(8):874-8. PubMed ID: 7838842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal heavy chain (immunoglobulin G3) deposition disease: report of a case.
    Herzenberg AM; Lien J; Magil AB
    Am J Kidney Dis; 1996 Jul; 28(1):128-31. PubMed ID: 8712207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unravelling the immunopathological mechanisms of heavy chain deposition disease with implications for clinical management.
    Bridoux F; Javaugue V; Bender S; Leroy F; Aucouturier P; Debiais-Delpech C; Goujon JM; Quellard N; Bonaud A; Clavel M; Trouillas P; Di Meo F; Gombert JM; Fermand JP; Jaccard A; Cogné M; Touchard G; Sirac C
    Kidney Int; 2017 Feb; 91(2):423-434. PubMed ID: 27773425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoglobulin gamma3-heavy-chain deposition disease: report of a case and relationship with hypocomplementemia.
    Soma J; Sato K; Sakuma T; Saito H; Sato H; Sato T; Abbas A; Aucouturier P
    Am J Kidney Dis; 2004 Jan; 43(1):E10-6. PubMed ID: 14712467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heavy chain deposition disease: an overview.
    Oe Y; Soma J; Sato H; Ito S
    Clin Exp Nephrol; 2013 Dec; 17(6):771-8. PubMed ID: 23652830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudo-gamma heavy chain (IgG4 lambda) deposition disease.
    Tubbs RR; Berkley V; Valenzuela R; McMahon JT; Gephardt GN; Fishleder AJ; Nally JV; Pohl MA; Bukowski RM; Lichtin AE
    Mod Pathol; 1992 Mar; 5(2):185-90. PubMed ID: 1574496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical remission and histopathological resolution of nodular lesions in a patient with gamma3 heavy-chain deposition disease.
    Soma J; Tsuchiya Y; Sakuma T; Sato H
    Clin Nephrol; 2008 May; 69(5):383-6. PubMed ID: 18538103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gamma-heavy chain deposition disease showing nodular glomerulosclerosis.
    Yasuda T; Fujita K; Imai H; Morita K; Nakamoto Y; Miura AB
    Clin Nephrol; 1995 Dec; 44(6):394-9. PubMed ID: 8719552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crescentic nodular glomerulosclerosis secondary to truncated immunoglobulin alpha heavy chain deposition.
    Cheng IK; Ho SK; Chan DT; Ng WK; Chan KW
    Am J Kidney Dis; 1996 Aug; 28(2):283-8. PubMed ID: 8768927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case report of light and heavy chain deposition disease (IgG2 lambda)].
    Akashi Y; Yoshizawa N; Oshima S; Takeuchi A; Kubota T; Kondo S; Oshikawa Y; Oda T; Suzuki Y; Shimizu J
    Nihon Jinzo Gakkai Shi; 1994 Sep; 36(9):1057-66. PubMed ID: 7967178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A concurrence of light and heavy chain deposition disease and diabetic nephropathy.
    Satirapoj B; Paueksakon P
    J Med Assoc Thai; 2007 Oct; 90(10):2204-8. PubMed ID: 18041443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.